| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Jin Medical International Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 08.09. | Jin Medical International Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 04.08. | Jin Medical International Ltd. - 6-K, Report of foreign issuer | 12 | SEC Filings | ||
| 04.08. | JIN MEDICAL INTERNATIONAL LTD. Reports First Half of Fiscal Year 2026 Financial Results | 248 | PR Newswire | CHANGZHOU, China, Aug. 4, 2026 /PRNewswire/ -- JIN MEDICAL INTERNATIONAL LTD. (Nasdaq: ZJYL) ("Jin Medical", and together with all its subsidiaries and consolidated... ► Artikel lesen | |
| 15.07. | Jin Medical International Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| JIN MEDICAL INTERNATIONAL Aktie jetzt für 0€ handeln | |||||
| 29.06. | Jin Medical International Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 04.06. | Jin Medical International Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 07.04. | Jin Medical International Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 07.04. | Jin Medical International Ltd. Has Regained Compliance with Nasdaq's Minimum Bid Price Requirement | 281 | PR Newswire | CHANGZHOU, China, April 7, 2026 /PRNewswire/ -- Jin Medical International Ltd. (NASDAQ: ZJYL) ("Jin Medical", and together with all its subsidiaries and consolidated... ► Artikel lesen | |
| 12.03. | Jin Medical International Ltd. Announces 1-for-20 Share Combination as Part of Strategic Nasdaq Compliance Initiative | 577 | PR Newswire | CHANGZHOU, China, March 11, 2026 /PRNewswire/ -- Jin Medical International Ltd. (NASDAQ: ZJYL) ("Jin Medical", and together with all its subsidiaries and consolidated... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CERENOME | 1,768 | +9,41 % | Cerenome, Inc.: Cerenome to Hold CNSide Business Update Call on September 30, 2026 | ||
| ATOSSA THERAPEUTICS | 1,790 | -5,29 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Aug. 7, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel... ► Artikel lesen | |
| ASENSUS SURGICAL | - | - | Karl Storz to fully integrate Asensus, discontinue Senhance, Luna robots | ||
| CO-DIAGNOSTICS | 1,095 | +0,46 % | Co-Diagnostics, Inc. - 8-K, Current Report | ||
| AMBU | 9,115 | -0,82 % | Ambu A/S: Interim Report For Q3 | 25.8.2026 18:01:05 CEST | Ambu A/S |
Interim report (Q1 and Q3)
In Q3 2025/26, Ambu delivered organic revenue growth of 10.3%, driven by strong performance in Endoscopy Solutions growing 16.0% organically.... ► Artikel lesen | |
| NOVACYT | 0,505 | 0,00 % | Novacyt S.A. - Notice of Results | ||
| AETHLON MEDICAL | 6,250 | -0,48 % | Aethlon Medical +564%: NBC-Empfehlung explodiert und lässt Mitglieder triumphieren | Die Microcap-Aktie von Aethlon Medical sorgt mit einem Kurssprung von satten +564 % für weltweites Aufsehen - und beschert Anlegern des No Brainer Club damit einen weiteren Mega-Volltreffer. Auslöser... ► Artikel lesen | |
| VIVOS THERAPEUTICS | 0,142 | +0,71 % | Vivos Therapeutics, Inc.: Vivos Therapeutics to Present at the 2026 Moody Capital Solutions Disruptive Growth & Life Sciences Conference | Littleton, Colorado--(Newsfile Corp. - September 1, 2026) - Vivos Therapeutics, Inc. (NASDAQ: VVOS) ("Vivos" or the "Company"), a leading medical technology and healthcare services company focused on... ► Artikel lesen | |
| FRESENIUS | 46,150 | +0,91 % | Fresenius baut Kapazität in Europa für 54 Mio Euro aus | DJ Fresenius baut Kapazität in Europa für 54 Mio Euro aus
DOW JONES--Fresenius hat seine Kapazitäten für die Herstellung von Infusionslösungen in Polen und Italien erweitert. Wie der DAX-Konzern... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 37,790 | +1,56 % | RBC stuft Siemens Healthineers auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat die Einstufung für Siemens Healthineers mit einem Kursziel von 45 Euro auf "Outperform" belassen. Natalia Webster verspricht sich laut ihrem... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,800 | +1,14 % | Fresenius Medical Care unter Attacke, KWS Saat enttäuscht mit Zahlen, Rheinmetall tankt wieder Zuversicht und SpaceX bekommt technischen Gegenwind | Hoffnungen auf eine Annäherung im Iran-Konflikt zerstreuten sich am Mittwoch schon wieder zum Teil, was den Ölpreis in höhere Regionen beförderte und damit Inflations- sowie Zinssorgen erneut anfachte.... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 8,215 | +0,06 % | Alignment Healthcare Reports Second Quarter 2026 Results, Surpassing High End of Guidance Across All Key Metrics | Generates $1.3 billion in total revenue, representing 31.6% growth year-over-year Grows Medicare Advantage membership 31.5% year-over-year to approximately 294,100 membersRaises the midpoint of all... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 12,410 | 0,00 % | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 56,61 | +0,04 % | Will M&A Be the Next Growth Factor as BTSG's Cash Flow and Leverage Improve? | ||
| FIREFLY NEUROSCIENCE | 2,020 | +0,50 % | Firefly Neuroscience und NeuroSigma kooperieren bei ADHS-Behandlung |